A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma - Meyer, T; Kirkwood, A; Roughton, M (Br J Cancer, 2013)
, et al.